Cargando…
Case Report: Severe rash/desquamation induced by sorafenib in an uHCC patient and its clinical management
Background: Sorafenib-related dermatological toxicity is a well-known adverse reaction that can severely affect therapeutic outcomes. Rash/desquamation with its variable manifestations is one of the common clinical presentations. Currently, no standard continuum of care for sorafenib-related rash/de...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514041/ https://www.ncbi.nlm.nih.gov/pubmed/36176447 http://dx.doi.org/10.3389/fphar.2022.994865 |